Similar articles

• Nitric oxide--another factor in cervical ripening.

  Calder AA. Calder AA. Hum Reprod. 1998 Feb;13(2):250-1. doi: 10.1093/humrep/13.2.250. Hum Reprod. 1998. PMID: 9557814 Review. No abstract available.
• Clinical application of nitric oxide donors and blockers.

  Romero R. Romero R. Hum Reprod. 1998 Feb;13(2):248-50. doi: 10.1093/humrep/13.2.248. Hum Reprod. 1998. PMID: 9557813 Review. No abstract available.
• Nitric oxide as the final metabolic mediator of cervical ripening.

  Chwalisz K, Garfield RE. Chwalisz K, et al. Hum Reprod. 1998 Feb;13(2):245-8. doi: 10.1093/humrep/13.2.245. Hum Reprod. 1998. PMID: 9557812 Review. No abstract available.
• Clinical use of nitric oxide donors and L-arginine in obstetrics.

  de Pace V, Chiossi G, Facchinetti F. de Pace V, et al. J Matern Fetal Neonatal Med. 2007 Aug;20(8):569-79. doi: 10.1080/14767050701419458. J Matern Fetal Neonatal Med. 2007. PMID: 17674274 Review.
• Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2).

  Ekerhovd E, Weijdegård B, Brännström M, Mattsby-Baltzer I, Norström A. Ekerhovd E, et al. Am J Obstet Gynecol. 2002 Apr;186(4):745-50. doi: 10.1067/mob.2002.121327. Am J Obstet Gynecol. 2002. PMID: 11967501 Clinical Trial.